Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EGFR and/or ROS Mutant NSCLC”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Early research (Phase 1)Ended earlyNCT01112397
What this trial is testing

Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours

Who this might be right for
Solid Malignancies
AstraZeneca 72
Early research (Phase 1)Ended earlyNCT01219543
What this trial is testing

A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.

Who this might be right for
Solid TumourAdvanced Solid MalignanciesChild-Pugh A to B7 Advanced Hepatocellular Carcinoma+3 more
AstraZeneca 47